Organogenesis Holdings Inc.
ORGO
$5.02
$0.000.00%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.01M | -8.23M | -15.88M | 861.00K | -7.38M |
| Total Depreciation and Amortization | 18.18M | 17.71M | 17.34M | 17.03M | 16.79M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.51M | 36.80M | 51.88M | 45.21M | 49.24M |
| Change in Net Operating Assets | -95.49M | -79.46M | -48.90M | -48.89M | -44.76M |
| Cash from Operations | -38.79M | -33.18M | 4.44M | 14.21M | 13.89M |
| Capital Expenditure | -12.86M | -13.19M | -11.44M | -10.03M | -10.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -12.86M | -13.19M | -11.44M | -10.03M | -10.00M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -63.49M | -64.88M | -66.26M | -67.64M | -6.80M |
| Issuance of Common Stock | 1.22M | 1.09M | 1.09M | 1.25M | 186.00K |
| Repurchase of Common Stock | -27.28M | -27.28M | -27.33M | -26.66M | -1.17M |
| Issuance of Preferred Stock | 120.69M | 120.69M | 120.69M | 120.69M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10.04M | -- | -- | -- | -- |
| Cash from Financing | 21.10M | 29.63M | 28.19M | 27.64M | -7.79M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -30.55M | -16.74M | 21.19M | 31.81M | -3.90M |